PIK3CA Cooperates with Other Phosphatidylinositol 3′-Kinase Pathway Mutations to Effect Oncogenic TransformationKatsutoshi Oda, Frank McCormick, Luika Timmerman et al.|Cancer Research|2008Cited by 193
Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial CarcinomasKeiko Shoji, Yuji Taketani|PLoS ONE|2012Cited by 82